The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Open accessAbstract
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases. Targeted resequencing of 70 aCMLs, 574 diverse hematological malignancies and 344 cancer cell lines identified SETBP1 mutations in 24 cases, including 17 of 70 aCMLs (24.3%; 95% confidence interval (CI) = 16–35%). Most mutations (92%) were located between codons 858 and 871 and were identical to changes seen in individuals with Schinzel-Giedion syndrome. Individuals with mutations had higher white blood cell counts (P = 0.008) and worse prognosis (P = 0.01). The p.Gly870Ser alteration abrogated a site for ubiquitination, and cells exogenously expressing this mutant exhibited higher amounts of SETBP1 and SET protein, lower PP2A activity and higher proliferation rates relative to those expressing the wild-type protein. In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Self-citationO'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Self-citationClinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
A minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Galaxy: A platform for interactive large-scale genome analysis
Giardine, B., Riemer, C., Hardison, R. C., Burhans, R., Elnitski, L., Shah, P., Zhang, Y., Blankenberg, D., Albert, I., Taylor, J., et al. (2005) · Genome Research · doi:10.1101/gr.4086505 · Cited by 2,026
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Self-citationThe clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Self-citationThe molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Differential expression in RNA-seq: A matter of depth
Tarazona, S., García-Alcalde, F., Dopazo, J., Ferrer, A., & Conesa, A. (2011) · Genome Research · doi:10.1101/gr.124321.111 · Cited by 1,632
Shah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J., & Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00096-x · Cited by 1,612
Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists
Blankenberg, D., Kuster, G. V., Coraor, N., Ananda, G., Lazarus, R., Mangan, M., Nekrutenko, A., & Taylor, J. (2010) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1910s89 · Cited by 1,427
The Biology of Chronic Myeloid Leukemia
Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,302
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Sawyers, C. L. (2002) · Blood · doi:10.1182/blood.v99.10.3530 · Cited by 1,146
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139
Self-citationOtt, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
BRAF Mutations in Hairy-Cell Leukemia
Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M. P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014209 · Cited by 1,024
Self-citationTalpaz, M. (2002) · Blood · doi:10.1182/blood.v99.6.1928 · Cited by 1,019
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Fialkow, P. J., Jacobson, R. J., & Papayannopoulou, T. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90124-3 · Cited by 857
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Cortes, J. E., Kantarjian, H., Shah, N. P., Bixby, D., Mauro, M. J., Flinn, I., O'Hare, T., Hu, S., Narasimhan, N. I., Rivera, V. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205127 · Cited by 769
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Shah, S. P., Köbel, M., Senz, J., Morin, R. D., Clarke, B. A., Wiegand, K. C., Leung, G., Zayed, A., Mehl, E., Kalloger, S. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902542 · Cited by 768
Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755
Introduction to the theory of nonparametric statistics
Randles, R. H., & Wolfe, D. A. (1979) · Krieger eBooks · Cited by 752
Analysing Survival Data From Clinical Trials and Observational Studies
(1996) · Technometrics · doi:10.1080/00401706.1996.10484530 · Cited by 663
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.
Marais, R., Light, Y., Paterson, H. F., & Marshall, C. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07316.x · Cited by 612
ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins
Puntervoll, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg545 · Cited by 602
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 572
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J., Sharkis, S., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 508
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome
Hoischen, A., van Bon, B. W. M., Gilissen, C., Arts, P., van Lier, B., Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N., Mortier, G., et al. (2010) · Nature Genetics · doi:10.1038/ng.581 · Cited by 489
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
Deininger, M. W. N., Goldman, J. M., Lydon, N., & Melo, J. V. (1997) · Blood · doi:10.1182/blood.v90.9.3691 · Cited by 482
Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 476
Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M., & Melo, J. V. (1998) · Blood · doi:10.1182/blood.v92.9.3362 · Cited by 463
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
ELM--the database of eukaryotic linear motifs
Dinkel, H., Michael, S., Weatheritt, R. J., Davey, N. E., Van Roey, K., Altenberg, B., Toedt, G., Uyar, B., Seiler, M., Budd, A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1064 · Cited by 438
Gordon, M. Y., Dowding, C. R., Riley, G. P., Goldman, J. M., & Greaves, M. F. (1987) · Nature · doi:10.1038/328342a0 · Cited by 436
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H., Sultan, C., & Cox, C. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb06734.x · Cited by 432
Gambacorti-Passerini, C., Antolini, L., Mahon, F.-X., Guilhot, F., Deininger, M., Fava, C., Nagler, A., Della Casa, C. M., Morra, E., Abruzzese, E., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr060 · Cited by 429
Self-citationPP2A: the expected tumor suppressor
Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426
Kantarjian, H. M., Smith, T. L., O'Brien, S., Beran, M., Pierce, S., Talpaz, M., & Service*, A. T. L. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-4-199502150-00003 · Cited by 417
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Azam, M., Seeliger, M. A., Gray, N. S., Kuriyan, J., & Daley, G. Q. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1486 · Cited by 411
Skorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M., Wen, S., Zon, G., Gewirtz, A., Perussia, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 404
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Raitano, A. B., Halpern, J. R., Hambuch, T. M., & Sawyers, C. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11746 · Cited by 394
Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G. N., Salvatore, F., & Rotoli, B. (1996) · Blood · doi:10.1182/blood.v88.7.2410.bloodjournal8872410 · Cited by 387
Grand, F. H., Hidalgo-Curtis, C. E., Ernst, T., Zoi, K., Zoi, C., McGuire, C., Kreil, S., Jones, A., Score, J., Metzgeroth, G., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194548 · Cited by 378
Self-citationPuttini, M., Coluccia, A. M. L., Boschelli, F., Cleris, L., Marchesi, E., Donella-Deana, A., Ahmed, S., Redaelli, S., Piazza, R., Magistroni, V., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1199 · Cited by 375
Self-citationIn Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Self-citationMolecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
Gambacorti-Passerini, C. B., Gunby, R. H., Piazza, R., Galietta, A., Rostagno, R., & Scapozza, L. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)00979-3 · Cited by 373
Self-citationJelinek, J., Oki, Y., Gharibyan, V., Bueso-Ramos, C., Prchal, J. T., Verstovsek, S., Beran, M., Estey, E., Kantarjian, H. M., & Issa, J.-P. J. (2005) · Blood · doi:10.1182/blood-2005-05-1800 · Cited by 369
NOONAN SYNDROME AND RELATED DISORDERS: Genetics and Pathogenesis
Tartaglia, M., & Gelb, B. D. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162305 · Cited by 355
Evan, G. I., Brown, L., Whyte, M., & Harrington, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80066-2 · Cited by 336
Gambacorti-Passerini, C., le Coutre, P., Mologni, L., Fanelli, M., Bertazzoli, C., Marchesi, E., Di Nicola, M., Biondi, A., Corneo, G. M., Belotti, D., et al. (1997) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.1997.0155 · Cited by 316
Self-citationAmarante-Mendes, G. P., Naekyung Kim, C., Liu, L., Huang, Y., Perkins, C. L., Green, D. R., & Bhalla, K. (1998) · Blood · doi:10.1182/blood.v91.5.1700 · Cited by 316
Chai, S. K., Nichols, G. L., & Rothman, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4720 · Cited by 280
Somatic SETBP1 mutations in myeloid malignancies
Makishima, H., Yoshida, K., Nguyen, N., Przychodzen, B., Sanada, M., Okuno, Y., Ng, K. P., Gudmundsson, K. O., Vishwakarma, B. A., Jerez, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2696 · Cited by 257
Vardiman, J. W. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.10.009 · Cited by 253
Tumor Heterogeneity and Personalized Medicine
Longo, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejme1200656 · Cited by 246
Kim, J. H., Chu, S. C., Gramlich, J. L., Pride, Y. B., Babendreier, E., Chauhan, D., Salgia, R., Podar, K., Griffin, J. D., & Sattler, M. (2005) · Blood · doi:10.1182/blood-2004-03-0849 · Cited by 238
Gesbert, F., Sellers, W. R., Signoretti, S., Loda, M., & Griffin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007291200 · Cited by 220
DNA Contents of Chromosome Ph 1 and Chromosome 21 in Human Chronic Granulocytic Leukemia
Rudkin, G. T., Hungerford, D. A., & Nowell, P. C. (1964) · Science · doi:10.1126/science.144.3623.1229 · Cited by 198
LIU, X., SUN, Y., WEINBERG, R., & LODISH, H. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00031-9 · Cited by 197
Increased neutrophil respiratory burst in bcr-null mutants
Voncken, J. W., Schaick, H. V., Kaartinen, V., Deemer, K., Coates, T., Landing, B., Pattengale, P., Dorseuil, O., Bokoch, G. M., Groffen, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90350-x · Cited by 197
Lichtman, M. A., Spivak, J. L., BOXER, L., et al. (2000) · Elsevier eBooks · doi:10.1016/b978-012448510-5/50134-5 · Cited by 187
Score, J., Hidalgo-Curtis, C., Jones, A. V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Ernst, T., Stegelmann, F., Döhner, K., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367243 · Cited by 177
Self-citationCristóbal, I., Blanco, F. J., Garcia-Orti, L., Marcotegui, N., Vicente, C., Rifon, J., Novo, F. J., Bandres, E., Calasanz, M. J., Bernabeu, C., et al. (2010) · Blood · doi:10.1182/blood-2009-06-227363 · Cited by 173
Chronic Myeloid Leukemia: A Historical Perspective
Goldman, J. M. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.07.001 · Cited by 137
IDH mutations in acute myeloid leukemia
Rakheja, D., Konoplev, S. N., Medeiros, L. J., & Chen, W. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.05.003 · Cited by 135
Sirard, C., Laneuville, P., & Dick, J. E. (1994) · Blood · doi:10.1182/blood.v83.6.1575.1575 · Cited by 133
Integrins Regulate the Association and Phosphorylation of Paxillin by c-Abl
Lewis, J. M., & Schwartz, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14225 · Cited by 127
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Rac GTPase interacts with GAPs and target proteins through multiple effector sites.
Diekmann, D., Nobes, C. D., Burbelo, P. D., Abo, A., & Hall, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00214.x · Cited by 123
Kabarowski, J. H. S., Allen, P. B., & Wiedemann, L. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06934.x · Cited by 109
Zou, X., Rudchenko, S., Wong, K., & Calame, K. L. (1997) · Genes & Development · doi:10.1101/gad.11.5.654 · Cited by 106
The Role and Challenges of Exome Sequencing in Studies of Human Diseases
Wang, Z., Liu, X., Yang, B., & Gelernter, J. E. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00160 · Cited by 104
BCR Rearrangement–Negative Chronic Myelogenous Leukemia Revisited
Kurzrock, R., Bueso-Ramos, C., Kantarjian, H. M., Freireich, E. J., Tucker, S. L., Siciliano, M. J., Pilat, S. R., & Talpaz, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2915 · Cited by 101
Defining and Managing Imatinib Resistance
Mauro, M. J. (2006) · Hematology · doi:10.1182/asheducation-2006.1.219 · Cited by 100
Onida, F., Ball, G., Kantarjian, H. M., Smith, T. L., Glassman, A. B., Albitar, M. X., Scappini, B., Rios, M. B., Keating, M. J., & Beran, M. (2002) · Cancer · doi:10.1002/cncr.10832 · Cited by 99
Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10
Oakley, K., Han, Y., Vishwakarma, B. A., Chu, S., Bhatia, R., Gudmundsson, K. O., Keller, J. R., Chen, X., Vasko, V. V., Jenkins, N. A., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388710 · Cited by 99
Minakuchi, M., Kakazu, N., Gorrín-Rivas, M. J., Abe, T., Copeland, T. D., Ueda, K., & Adachi, Y. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02000.x · Cited by 96
Chronic myelogenous leukemia: A review and update of therapeutic strategies
Garcia‐Manero, G., Faderl, S. H., O'Brien, S. M., Cortes, J. E., Talpaz, M., & Kantarjian, H. M. (2003) · Cancer · doi:10.1002/cncr.11520 · Cited by 95
BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia
Burke, B. A., & Carroll, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.67 · Cited by 92
Kurzrock, R., Kantarjian, H., Shtalrid, M., Gutterman, J., & Talpaz, M. (1990) · Blood · doi:10.1182/blood.v75.2.445.445 · Cited by 91
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
Ernst, T., Chase, A., Zoi, K., Waghorn, K., Hidalgo-Curtis, C., Score, J., Jones, A. V., Grand, F., Reiter, A., Hochhaus, A., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.021808 · Cited by 78
Self-citationPart I: Milestones in personalised medicine—imatinib
Gambacorti-Passerini, C. B. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70152-9 · Cited by 68
Self-citationAllogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
Nicolini, F. E., Basak, G. W., Soverini, S., Martinelli, G., Mauro, M. J., Müller, M. C., Hochhaus, A., Chuah, C. T. H., Dufva, I. H., Rege‐Cambrin, G., et al. (2011) · Blood · doi:10.1182/blood-2011-07-367326 · Cited by 60
SAMMate: a GUI tool for processing short read alignments in SAM/BAM format
Xu, G., Deng, N., Zhao, Z., Judeh, T., Flemington, E. K., & Zhu, D. (2011) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-6-2 · Cited by 60
Panagopoulos, I., Kerndrup, G. B., Carlsen, N., Strömbeck, B., Isaksson, M., & Johansson, B. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06410.x · Cited by 57
The effects of TGF-beta on bone.
Mundy, G. R. (1991) · PubMed · Cited by 55
Schinzel–Giedion syndrome: Report of splenopancreatic fusion and proposed diagnostic criteria
Lehman, A., McFadden, D. E., Pugash, D., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32277 · Cited by 54
Fend, F., Horn, T., Koch, I., Vela, T., & Orazi, A. (2008) · Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis · doi:10.1016/j.leukres.2008.04.024 · Cited by 48
Manfredini, R., Zini, R., Salati, S., Siena, M., Tenedini, E., Tagliafico, E., Montanari, M., Zanocco‐Marani, T., Gemelli, C., Vignudelli, T., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0265 · Cited by 45
Molecular basis of myelodysplastic/myeloproliferative neoplasms
Reiter, A., Invernizzi, R., Cross, N. C. P., & Cazzola, M. (2009) · Haematologica · doi:10.3324/haematol.2009.014001 · Cited by 44
Self-citationHigh Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion
Keeshan, K., Cotter, T. G., & McKenna, S. L. (2002) · Leukemia · doi:10.1038/sj.leu.2402576 · Cited by 44
Fernández‐Mercado, M., Pellagatti, A., Genua, C. D., Larráyoz, M. J., Winkelmann, N., Aranaz, P., Burns, A., Schuh, A., Calasanz, M. J., Cross, N. C. P., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12491 · Cited by 43
Self-citationFusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery
Piazza, R., Pirola, A., Spinelli, R., Valletta, S., Redaelli, S., Magistroni, V., & Gambacorti-Passerini, C. B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks394 · Cited by 33
Self-citationDevelopment and targeted use of nilotinib in chronic myeloid leukemia
Jabbour, E. J. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s3181 · Cited by 31
Bosutinib in the management of chronic myelogenous leukemia
Keller-v.Amsberg, G., & Schafhausen (2013) · Biologics · doi:10.2147/btt.s30182 · Cited by 25
Silencing of ASXL 1 impairs the granulomonocytic lineage potential of human CD 34+ progenitor cells
Davies, C. H., Yip, B. H., Fernández‐Mercado, M., Woll, P. S., Agirre, X., Prósper, F., Jacobsen, S. E. W., Wainscoat, J. S., Pellagatti, A., & Boultwood, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12217 · Cited by 23
Self-citationHistone modification defects in developmental disorders and cancer
Cross, N. C. P. (2012) · Oncotarget · doi:10.18632/oncotarget.436 · Cited by 20
Self-citationGodley, L. A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1200409 · Cited by 19
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia
Ashraf, M. S., Noguera, N. I., Giandomenico, J. D., Zaza, S., Hasan, S. K., & Lo‐Coco, F. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1868-0 · Cited by 9
Mundy, G. R. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514061.ch9 · Cited by 7
Cited by
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
High-throughput discovery of novel developmental phenotypes
The International Mouse Phenotyping Consortium, Dickinson, M. E., Flenniken, A. M., Ji, X., Teboul, L., Wong, M. D., White, J. K., Meehan, T. F., Weninger, W. J., Westerberg, H., et al. (2016) · Nature · doi:10.1038/nature19356 · Cited by 1,196
Metadata
- Authors
- Piazza, R., Valletta, S., Winkelmann, N., Redaelli, S., Spinelli, R., Pirola, A., Antolini, L., Mologni, L., Donadoni, C., Papaemmanuil, E., Schnittger, S., Kim, D.-W., Boultwood, J., Rossi, F., Gaipa, G., De Martini, G. P., di Celle, P. F., Jang, H. G., Fantin, V., Bignell, G. R., Magistroni, V., Haferlach, T., Pogliani, E. M., Campbell, P. J., Chase, A. J., Tapper, W. J., Cross, N. C. P., & Gambacorti-Passerini, C.
- Venue
- Nature Genetics
- Published
- 2012-12-09
- Volume
- 45
- Issue
- 1
- Pages
- 18-24
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2138122783
- Cited by
- 403
- References
- 125
- FWCI
- 24.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.